Clinical Trials · NCT00580450
Thymosin Alfa 1 in Recipients of Allogeneic Hematopoietic Transplantation for Hematological Malignancies
- Phase
- Phase 1/Phase 2
- Recruitment status
- Unknown
- Sponsor
- University Of Perugia
- Enrollment
- 9
- Start date
- Dec 2007
- Locations
- 1 site, Italy
- Primary endpoint
- Efficacy in terms of improvement of immunological reconstitution, infectious mortality; safety as prevention of GvHD.